GCC Agonist Signal in the Small Intestine

Clinical trial NCT05107219 · COMPLETED

Trial details

NCT number: NCT05107219
Sponsor: University of Wisconsin, Madison
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Barrett Esophagus Gastroesophageal Reflux Disease Malignant Digestive System Neoplasm

Start date: 2022-11-30
Primary completion: 2026-02-06
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.